IDRX-42 is a small-molecule compound that acts as an inhibitor of the c-Kit receptor tyrosine kinase. It is under investigation as a potential pharmaceutical raw material for targeting certain mutant forms of this kinase.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing or supplying this compound?
List your inventory or post a purchase request
CAS 2590556-80-0
Crenolanib
pharmaceutical raw material
Neratinib
pharmaceutical raw material
Xl-228
pharmaceutical raw material
Wz-4002
pharmaceutical raw material
Cefazolin
pharmaceutical raw material
Favipiravir
pharmaceutical raw material
Fosfomycin calcium
pharmaceutical raw material
Fosfomycin sodium
pharmaceutical raw material
N-[[4-(1-methylpyrazol-4-yl)phenyl]methyl]-6-[7-(3-pyrrolidin-1-ylpropoxy)imidazo[1,2-a]pyridin-3-yl]pyrimidin-4-amine
LVMAULGVWBINFP-UHFFFAOYSA-N
CN1C=C(C=N1)C2=CC=C(C=C2)CNC3=NC=NC(=C3)C4=CN=C5N4C=CC(=C5)OCCCN6CCCC6